| Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells S Pajaniradje, K Mohankumar, R Pamidimukkala, S Subramanian, ... BioMed research international 2014, 2014 | 109 | 2014 |
| Flavonoids: structure–function and mechanisms of action and opportunities for drug development S Safe, A Jayaraman, RS Chapkin, M Howard, K Mohankumar, ... Toxicological research 37, 147-162, 2021 | 73 | 2021 |
| Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin–an in vitro and in silico approach K Mohankumar, S Pajaniradje, S Sridharan, VK Singh, L Ronsard, ... Chemico-biological interactions 210, 51-63, 2014 | 64 | 2014 |
| Aryl hydrocarbon receptor (AhR) ligands as selective AhR modulators: Genomic studies S Safe, H Han, J Goldsby, K Mohankumar, RS Chapkin Current opinion in toxicology 11, 10-20, 2018 | 52 | 2018 |
| BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway—a comparative study with curcumin K Mohankumar, S Sridharan, S Pajaniradje, VK Singh, L Ronsard, ... Biomedicine & pharmacotherapy 74, 178-186, 2015 | 38 | 2015 |
| Anti-proliferative and apoptosis-triggering potential of disulfiram and disulfiram-loaded polysorbate 80-stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line M Hoda, S Pajaniradje, G Shakya, K Mohankumar, R Rajagopalan Nanomedicine: Nanotechnology, Biology and Medicine 12 (6), 1641-1650, 2016 | 37 | 2016 |
| Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study with curcumin M Kumaravel, P Sankar, P Latha, CS Benson, R Rukkumani Natural product communications 8 (2), 1934578X1300800213, 2013 | 35 | 2013 |
| Antiproliferative effect of an analog of curcumin bis-1, 7-(2-hydroxyphenyl)-hepta-1, 6-diene-3, 5-dione in human breast cancer cells. M Kumaravel, P Sankar, R Rukkumani European Review for Medical & Pharmacological Sciences 16 (14), 2012 | 35 | 2012 |
| Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice S Sridharan, K Mohankumar, SPK Jeepipalli, D Sankaramourthy, ... Neurotoxicology 51, 172-183, 2015 | 34 | 2015 |
| Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth R Shrestha, K Mohankumar, G Martin, A Hailemariam, S Lee, U Jin, ... Journal of Experimental & Clinical Cancer Research 40, 1-17, 2021 | 31 | 2021 |
| A Bis-Indole–Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity K Karki, GA Wright, K Mohankumar, UH Jin, XH Zhang, S Safe Cancer research 80 (5), 1011-1023, 2020 | 31 | 2020 |
| Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists E Hedrick, X Li, Y Cheng, A Lacey, K Mohankumar, M Zarei, S Safe Breast cancer research and treatment 177, 29-40, 2019 | 29 | 2019 |
| TGFβ-induced lung cancer cell migration is NR4A1-dependent E Hedrick, K Mohankumar, S Safe Molecular Cancer Research 16 (12), 1991-2002, 2018 | 28 | 2018 |
| Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways K Mohankumar, S Pajaniradje, S Sridharan, VK Singh, L Ronsard, ... Cellular oncology 37, 439-454, 2014 | 27 | 2014 |
| Reactive oxygen species (ROS)-inducing triterpenoid inhibits rhabdomyosarcoma cell and tumor growth through targeting SP transcription factors R Kasiappan, I Jutooru, K Mohankumar, K Karki, A Lacey, S Safe Molecular Cancer Research 17 (3), 794-805, 2019 | 26 | 2019 |
| Synthesis, in vitro and in silico anti-proliferative activity of 4-aryl-4H-chromene derivatives A Parthiban, M Kumaravel, J Muthukumaran, R Rukkumani, R Krishna, ... Medicinal Chemistry Research 25, 1308-1315, 2016 | 26 | 2016 |
| Design, synthesis, in vitro and in silico anticancer activity of 4H-chromenes with C4-active methine groups A Parthiban, M Kumaravel, J Muthukumaran, R Rukkumani, R Krishna, ... Medicinal Chemistry Research 24 (3), 1226-1240, 2015 | 26 | 2015 |
| Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas K Karki, X Li, UH Jin, K Mohankumar, M Zarei, SK Michelhaugh, S Mittal, ... Journal of Neuro-oncology 146, 25-39, 2020 | 25 | 2020 |
| Bis-Indole–Derived NR4A1 Ligands and Metformin Exhibit NR4A1-Dependent Glucose Metabolism and Uptake in C2C12 Cells K Mohankumar, J Lee, CS Wu, Y Sun, S Safe Endocrinology 159 (5), 1950–1963, 2018 | 25 | 2018 |
| Orphan nuclear receptor 4A1 (NR4A1) and novel ligands S Safe, R Shrestha, K Mohankumar Essays in biochemistry 65 (6), 877-886, 2021 | 23 | 2021 |
